Literature DB >> 34191371

Impact of pre-ablation weight loss on the success of catheter ablation for atrial fibrillation.

Graham Peigh1, Jeremiah Wasserlauf2, Kelly Vogel1, Rachel M Kaplan1, Anna Pfenniger1, Daniel Marks1, Arjun Mehta1, Alexandru B Chicos1, Rishi Arora1, Susan Kim1, Albert Lin1, Nishant Verma1, Kaustubha D Patil1, Bradley P Knight1, Rod S Passman1.   

Abstract

INTRODUCTION: Obesity is an established risk factor for recurrent atrial fibrillation (AF) after ablation. The impact of pre-procedure weight changes on freedom from AF (FFAF) after ablation in obese and nonobese patients is unknown.
METHODS: A single-center retrospective cohort study of patients undergoing pulmonary vein isolation was performed. Before ablation, all candidates were encouraged to adopt healthy lifestyle habits according to American Heart Association guidelines, including weight loss, by their physician. The primary endpoint was FFAF through 1-year after completion of the 3-month blanking period.
RESULTS: Of the 601 patients (68% male; average age 62.1 ± 10.3 years) included in analysis, 234 patients (38.9%) were obese (body mass index ≥ 30) and 315 (52.4%) had paroxysmal AF. FFAF was observed in 420 patients (69.9%) at 15 months. Percent change in weight that occurred during the year before ablation independently predicted FFAF through 15-months in all patients (adjusted odds ratio =  1.17, 95% confidence interval: 1.11-1.23). Subgroup analyses based on paroxysmal vs persistent AF, presence of obesity, and history of prior ablation were performed. Percent change in weight over the year before ablation was independently associated with FFAF in all subgroups except nonobese patients with persistent AF.
CONCLUSION: Pre-ablation weight loss was associated with FFAF in both obese and nonobese patients. Further studies are needed to define the optimal approach to weight loss before AF ablation.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; cryoballoon; pulmonary vein isolation; weight loss

Mesh:

Year:  2021        PMID: 34191371      PMCID: PMC9305992          DOI: 10.1111/jce.15141

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873            Impact factor:   2.942


  25 in total

1.  Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation.

Authors:  Thomas M Munger; Ying-Xue Dong; Mitsuru Masaki; Jae K Oh; Sunil V Mankad; Barry A Borlaug; Samuel J Asirvatham; Win-Kuang Shen; Hon-Chi Lee; Suzette J Bielinski; David O Hodge; Regina M Herges; Traci L Buescher; Jia-Hui Wu; Changsheng Ma; Yanhua Zhang; Peng-Sheng Chen; Douglas L Packer; Yong-Mei Cha
Journal:  J Am Coll Cardiol       Date:  2012-06-20       Impact factor: 24.094

2.  Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients.

Authors:  Bhradeev Sivasambu; Muhammad A Balouch; Tarek Zghaib; Rizma J Bajwa; Jonathan Chrispin; Ronald D Berger; Hiroshi Ashikaga; Saman Nazarian; Joseph E Marine; Hugh Calkins; David D Spragg
Journal:  J Cardiovasc Electrophysiol       Date:  2017-12-14

3.  Long-Term Outcomes After Ablation for Paroxysmal Atrial Fibrillation Using the Second-Generation Cryoballoon: Final Results From STOP AF Post-Approval Study.

Authors:  Bradley P Knight; Paul G Novak; Robert Sangrigoli; Jean Champagne; Marc Dubuc; Stuart W Adler; J Thomas Svinarich; Vidal Essebag; Robert Hokanson; Fred Kueffer; Sandeep K Jain; Roy M John; Moussa Mansour
Journal:  JACC Clin Electrophysiol       Date:  2018-12-26

4.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  J Arrhythm       Date:  2017-09-15

5.  Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study.

Authors:  Rajeev K Pathak; Melissa E Middeldorp; Dennis H Lau; Abhinav B Mehta; Rajiv Mahajan; Darragh Twomey; Muayad Alasady; Lorraine Hanley; Nicholas A Antic; R Doug McEvoy; Jonathan M Kalman; Walter P Abhayaratna; Prashanthan Sanders
Journal:  J Am Coll Cardiol       Date:  2014-11-24       Impact factor: 24.094

6.  Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity.

Authors:  Rajiv Mahajan; Dennis H Lau; Anthony G Brooks; Nicholas J Shipp; Jim Manavis; John P M Wood; John W Finnie; Chrishan S Samuel; Simon G Royce; Darragh J Twomey; Shivshanker Thanigaimani; Jonathan M Kalman; Prashanthan Sanders
Journal:  J Am Coll Cardiol       Date:  2015-07-07       Impact factor: 24.094

7.  PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study.

Authors:  Melissa E Middeldorp; Rajeev K Pathak; Megan Meredith; Abhinav B Mehta; Adrian D Elliott; Rajiv Mahajan; Darragh Twomey; Celine Gallagher; Jeroen M L Hendriks; Dominik Linz; R Doug McEvoy; Walter P Abhayaratna; Jonathan M Kalman; Dennis H Lau; Prashanthan Sanders
Journal:  Europace       Date:  2018-12-01       Impact factor: 5.214

8.  Repeat pulmonary vein isolation with or without FIRM-guided ablation for recurrent atrial fibrillation with pulmonary vein reconnection.

Authors:  Graham Peigh; Jeremiah Wasserlauf; Rachel M Kaplan; Ansel P Amaral; Amar Trivedi; Alexandru B Chicos; Rishi Arora; Susan Kim; Albert Lin; Nishant Verma; Bradley P Knight; Rod S Passman
Journal:  J Cardiovasc Electrophysiol       Date:  2020-03-09       Impact factor: 2.942

9.  Impact of Body Mass Index on the Outcomes of Catheter Ablation of Atrial Fibrillation: A European Observational Multicenter Study.

Authors:  Rui Providência; Pedro Adragão; Carlo de Asmundis; Julian Chun; Gianbattista Chierchia; Pascal Defaye; Frédéric Anselme; Antonio Creta; Pier D Lambiase; Boris Schmidt; Shaojie Chen; Diogo Cavaco; Ross J Hunter; João Carmo; Stephane Combes; Shohreh Honarbakhsh; Nicolas Combes; Maria João Sousa; Zeynab Jebberi; Jean-Paul Albenque; Serge Boveda
Journal:  J Am Heart Assoc       Date:  2019-10-04       Impact factor: 5.501

View more
  1 in total

1.  Safety, efficacy, and cost-performance of a simplified cryoballoon ablation procedure for paroxysmal atrial fibrillation.

Authors:  Yasuhiro Matsuda; Masaharu Masuda; Takashige Sakio; Mitsutoshi Asai; Osamu Iida; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Takashi Kanda; Takuya Tsujimura; Yosuke Hata; Hiroyuki Uematsu; Toshiaki Mano
Journal:  J Interv Card Electrophysiol       Date:  2021-08-12       Impact factor: 1.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.